Before experiments to evaluate the effect of GIPC1 depletion in sensitizing pancreatic cancer cells towards chemotherapeutic drugs, we analyzed the GIPC1 expression levels in AsPC-1, PANC-1, and some PDX cell lines. This evidence concerns the gene GIPC1 and familial pancreatic carcinoma.